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Background: Growing evidence suggests that epicardial adipose tissue (EAT) may contribute to the development
of coronary artery disease (CAD). In this study, we explored gender disparities in EAT volume (EATV) and its impact
on coronary atherosclerosis.
Methods: The study population consisted of 90 consecutive subjects (age: 63 ± 12 years; men: 47, women: 43) who
underwent 256-slice multi-detector computed tomography (MDCT) coronary angiography. EATV was measured as
the sum of cross-sectional epicardial fat area on CT images, from the lower surface of the left pulmonary artery
origin to the apex. Subjects were segregated into the CAD group (coronary luminal narrowing > 50%) and
non-CAD group.
Results: EATV/body surface area (BSA) was higher among men in the CAD group than in the non-CAD group
(62 ± 13 vs. 33 ± 10 cm3/m2, p < 0.0001), but did not differ significantly among women in the 2 groups (49 ± 18
vs. 42 ± 9 cm3/m2, not significant). Multivariate logistic analysis showed that EATV/BSA was the single predictor for
>50% coronary luminal narrowing in men (p < 0.0001). Predictors excluded were age, body mass index,
hypertension, diabetes mellitus, and hyperlipidemia.
Conclusions: Increased EATV is strongly associated with coronary atherosclerosis in men.
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Epicardial adipose tissue (EAT) is the visceral fat located
between the outer layer of the myocardium and the
visceral pericardium [1-4]. EAT volume (EATV) is corre-
lated with various cardiovascular risk factors, independ-
ent of abdominal visceral adiposity, body mass index
(BMI), hypertension, and diabetes mellitus [5-7]. Two
population-based studies, the Multi-Ethnic Study of
Atherosclerosis and the Framingham Heart Study,
showed that EATV is an independent risk predictor for
cardiovascular disease [5,8,9]. EAT is shown to be meta-
bolically active and the source of pro-atherogenic media-
tors and adipocytokines [1-5]. Because EAT and the
myocardium are located close anatomically, it is pre-
dicted that cytokines/adipocytokines produced by infil-
trated macrophages or by adipocytes could locally
modulate myocardial function or contribute to the
pathogenesis of coronary atherosclerosis [1-5]. Recently,
we [10,11] and others [12] showed that proinflammatory
cytokines and adipocytokines are expressed and secreted
at a higher level in the adipose tissue of individuals with
coronary artery disease (CAD) than in individuals with-
out CAD.
Abdominal fat distribution is dissimilar between men
and women: Visceral fat obesity is the dominant form in
men, while subcutaneous fat obesity is the dominant
form in women [13,14]. However, gender differences in
EATV distribution and the influence of EAT on coron-
ary atherosclerosis has never been considered. In this
study, we evaluated gender disparities in EATV and its
impact on coronary atherosclerosis by using 256-slice
multi-detector computed tomography (MDCT).
Subjects and methods
Subjects
We recruited 119 consecutive subjects who underwent
256-slice MDCT coronary angiography between Octo-
ber 2009 and April 2011 at the Kawashima Hospital,
Tokushima, Japan. The subjects underwent MDCT if
they had atherosclerotic risk factors such as age ≥65
years [15], hypertension, smoking, diabetes mellitus, or
dyslipidemia or symptoms suggestive of angina pectoris.
According to the 2010 Appropriate Use Criteria for
Cardiac Computed Tomography [16] guidelines, cardiac
CT is not necessarily recommended for asymptomatic
individuals with low-to-moderate CAD risk. However,
the prevalence of CAD was not negligible even in
asymptomatic subgroups [17]; hence, we employed
MDCT in subjects with moderate-to-high CAD risk
after they were informed of the radiation-exposure
related risk, and they provided written informed con-
sent. Coronary CT angiography was performed using a
256-slice scanner (Brilliance iCT, Philips Healthcare,
Amsterdam, Netherlands), and the diagnostic accuracyof the coronary CT angiography for coronary luminal
narrowing was validated by routine invasive coronary
angiography. Exclusion criteria included a history of
cardiac surgery, iodine-based contrast allergy, or renal
failure (creatinine, >1.5 mg/dL). Hypertension was
defined as a systolic blood pressure of ≥140 mm Hg
and/or diastolic blood pressure of ≥90 mm Hg or as
the current use of antihypertensive treatment. Diabetes
was defined as fasting plasma glucose of ≥6.99 mmol/L
(126 mg/dL) or the current use of hypoglycemic treat-
ment. Hyperlipidemia was defined as fasting serum
LDL-cholesterol of ≥3.62 mmol/L (140 mg/dL), HDL-
cholesterol of <1.03 mmol/L (40 mg/dL), triglyceride of
≥1.58 mmol/L (140 mg/dL), and/or the current use of
antihyperlipidemic treatment. The subjects were segre-
gated into 2 groups: CAD group (presence of plaques
resulting in >50% luminal narrowing in the major cor-
onary arteries) and non-CAD group (no plaque or pla-
ques resulting in ≤50% luminal narrowing). All subjects
in the CAD and non-CAD groups were further segre-
gated into younger (age, <65 years) and older subgroup
(age, ≥65 years).
Multi-detector CT scan protocol
The Cardiac MDCT acquisition was performed with
retrospective ECG-gated cardiac imaging. The MDCT
scan was performed using the following parameters: de-
tector collimation of 2 × 128 × 0.625 mm, creating
256 overlapping slices of 0.625-mm thickness via a dy-
namic z-flying focal spot, gantry rotation time of 0.27 s,
and tube voltage 120 kVp. A current of 800–1050 mA
(depending on patient habitus) was used for helical acquisi-
tions and a current of 200 mA for axial acquisitions.
Computed tomography dose index volume (CTDIV) was
calculated as 74.1 ± 12.6 mGy (n = 50). The raw scan
data were reconstructed with 75% of RR wave or par-
ticular optimal phase. A bolus dose of the contrast
medium (Iohexol [Omnipaque; Daiichi-Sankyo Pharma-
ceutical, Tokyo, Japan], containing 350 mg iodine/mL) was
injected at 0.7 mL/kg body weight within 9 s. Nitro-
glycerin (0.3 mg) was administered to all subjects imme-
diately before CT imaging, and an oral β blocker
(metoprolol, 60 or 120 mg) was administered 1 h before
CT imaging to render heart rates <65 beats/min, if
required.
Analysis of EATV
We performed volumetric quantification of EAT mea-
sured by the 256-slice MDCT, as described with some
modifications [18-22] (Figure 1). Quantification of total
EAT area (cm2) was performed at a workstation (Real-
INTAGE, Kubota, Japan) with dedicated software. Volu-
metric measurements were performed on axial views of
0.625-mm slice thickness and number of slices ranging
Figure 1 Total epicardial adipose tissue volume (EATV) measurements on 256-slice MDCT. (A)–(C): Axial images. A region of interest (ROI)
was manually placed along the visceral pericardium (yellow line) (A) and EAT was extracted on an axial image (green) (B, C). (D) 3D image: EAT
area was measured on each axial image from the lower surface of left pulmonary artery origin to the left ventricular apex and total EAT volume
was obtained from multiplying EAT area and the slice thickness.
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measurements was the lower surface of the left pulmon-
ary artery origin, while the inferior border was the left
ventricular apex. The EAT area around the proximal,
middle, and distal segment of the major coronary arter-
ies was included in the volumetric measurements. The
EAT area was calculated by tracing a region of interest
(ROI), which included the heart and EAT. The ROI was
manually placed outside the line of the visceral pericar-
dium on a cross-sectional axial image (yellow line, Fig-
ure 1). The area outside the traced pericardium was
excluded. A density range of -600 to -20 Hounsfield
Units was used to isolate the adipose tissue. The EAT
area of each slice was then summed and multiplied by
the slice thickness and number of slices to determine
the total EATV (cm3).
Assessment of coronary atherosclerosis
The presence of coronary atherosclerosis was estimated
by CT angiographical data using a 256-slice Brilliance
iCT (Philips Medical Systems). Coronary arteries were
assessed for luminal narrowing by using 3D visualization
tools after the axial images were reviewed for determin-
ation of anatomy, quality of the study, and appearance of
the vessels. The coronary artery tree was segmented
according to the modified American Heart Association
classification [23]. Coronary vessel and diameter wereassessed on 2D multiplanar reconstruction (MPR) and
2D thin slab maximum intensity projection (MIP)
images. A 3D volume rendered (VR) image was used to
display long segments of the vessels and their branches.
To compare the possible gender differences in the calci-
fied lesion, we compared the Agatston scores between
the men and women in CAD and non-CAD [24].
Statistical analysis
Values are expressed as mean ± SD unless otherwise
indicated. For comparison of the mean in the 2 groups,
we used unpaired t-test when samples were normally
distributed and non-parametric Mann-Whitney's U test
when samples were not normally distributed. χ2 test was
used to examine differences with categorical variables.
Multigroup comparisons of variables were performed
using one-way ANOVA followed by Tukey-Kramer HSD
(honestly significant difference) test. Multiple logistic re-
gression analysis was performed to adjust confounding
factors. Variables were treated as continuous: one with a
risk as 1 and one with no risk, i.e., as 0. We investigated
the independent variables for detecting coronary artery
luminal narrowing (>50%) by using unadjusted (univari-
ate) and adjusted style (multivariate) for age, BMI, and
other established risk factors (hypertension, hyperlipid-
emia, and diabetes mellitus). All analyses were per-
formed using Jump version 9.0.2 software (SAS Institute
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Of the 119 subjects who underwent cardiac MDCT, 29
were excluded from analysis. Among the men, 11 were
excluded because of differences in slice levels and 2 be-
cause of insufficient image quality; among the women, 11
were excluded because of differences in slice levels and 5
because of insufficient image quality. A total of 90 sub-
jects (men: n = 47; age = 63 ± 12 years; women: n = 43,
age = 64 ± 12 years) were analyzed (Table 1). By using
MDCT, 22 men and 16 women were segregated into the
CAD group (>50% luminal narrowing), while 25 men
and 27 women were segregated into the non-CAD group.
Among the 47 men, 36 (77%) had normal weight (BMI <
25 kg/m2), 8 (17%) were overweight (BMI 25–30 kg/m2),
and 3 (6%) were obese (BMI > 30 kg/m2). Among the 43
women, 33 (77%) had normal weight (BMI < 25 kg/m2),
7 (16%) were overweight (BMI 25–30 kg/m2), and 3 (7%)
were obese (BMI > 30 kg/m2). When the non-CAD and
CAD groups were combined, we found that the EATV
was higher in men than in women (80 ± 33 vs. 65 ± 21
cm3; p = 0.0089), but the mean EATV/height and EATV/
BSA were comparable (Table 1).Table 1 Characteristics of the study population
Men
All non-CAD CAD
Patient, n 47 25 22
Age (years) 61 ± 13 56 ± 13 67 ± 9
Body weight (kg) 65.9 ± 10.9 66.4 ± 12.3 65.3 ± 9.2
Body mass index (kg/m2) 24.0 ± 3.5 24.2 ± 4.4 23.9 ± 2.0
Systolic blood pressure (mmHg) 134 ± 2 136 ± 17 131 ± 12
Diastolic blood pressure (mmHg) 76 ± 1 75 ± 7 77 ± 9
LDL-cholesterol (mmol/L) 2.54 ± 0.49 2.47 ± 0.46 2.52 ± 0.61
HDL-cholesterol (mmol/L) 1.09 ± 0.28 1.09 ± 0.18 0.97 ± 0.15
Triglyceride (mmol/L) 1.47 ± 0.46 2.07 ± 1.84 1.82 ± 0.67
Glucose (mmol/L) 7.55 ± 2.72 6.83 ± 1.61
HbA1c (NGSP %) 6.85 ± 1.72 6.85 ± 0.57 6.84 ± 0.50
Hypertension (%) 71 63 81
Diabetes mellitus (%) 40 33 48
Hyperlipidemia (%) 83 78 83
EATV (cm3) 80 ± 33 57 ± 21 106 ± 23
EATV/height (cm3/m2) 47 ± 19 96 ± 37 176 ± 40
EATV/BSA (cm3/m2) 48 ± 20 33 ± 10 62 ± 13
Agatston score 502 ± 926 582 ± 400 400 ± 637
Values are means ± SD. P1:p values vs Non-CAD, P2:p values vs Men. ns: not signific
density lipoprotein; HbA1c : Glycosylated hemoglobin, NGSP: National Glycohemoglo
body surface area.Distribution of BMI and EATV/BSA in non-CAD and CAD
subjects
EATV, EATV/height, and EATV/BSA were considerably
higher among men in the CAD group than in those in
the non-CAD group (Figure 2B-D) but not significantly
different among women in the non-CAD and CAD
groups (Figure 2B-D). BMI was not different in both
groups (Figure 2A). Because age was higher in the CAD
group than in the non-CAD group (Table 1), we tried to
minimize the confounding effects of age by comparing
patients in the younger (<65 years) and older (≥65 years)
subgroups. EATV, EATV/height, and EATV/BSA were
higher among men in the CAD group than in the non-
CAD group both in younger (<65 years) and older (≥65
years) subgroups; however, in women, no significant dif-
ference was found in these values (Additional file 1 and
Additional file 2).
Next, we examined the relationship between the de-
gree of coronary artery stenosis and EATV. Subjects
were divided into the following categories: grade 0 = no
plaques in the major coronary branches; grade 1 = ≤25%
luminal narrowing; grade 2 = ≤50% luminal narrowing;
grade 3 = >50% luminal narrowing. EATV/BSA was lar-
ger among men in grade 2 and grade 3 than in grade 1
(Figure 3). In men and women, the Agatston score did
not differ between the non-CAD and CAD groupsWomen
P1 All P2 non-CAD CAD P1
43 27 16
0.0025 66 ± 12 ns 65 ± 10 65 ± 13 ns
ns 53.4 ± 1.5 0.001 54.8 ± 8.5 51.0 ± 9.5 ns
ns 23.3 ± 3.5 ns 23.9 ± 3.0 22.3 ± 4.1 ns
ns 135 ± 3 ns 132 ± 14 140 ± 24 ns
ns 77 ± 6 ns 77 ± 6 77 ± 8 ns
ns 3.00 ± 0.60 0.01 3.11 ± 0.49 2.90 ± 0.28 ns
ns 1.63 ± 0.54 <0.0001 1.68 ± 0.52 1.89 ± 0.34 ns
ns 1.50 ± 0.82 ns 1.39 ± 0.04 1.25 ± 0.44 ns
ns 6.27 ± 1.67 9.71 ± 7.99 ns
ns 6.15 ± 0.98 ns 6.39 ± 0.35 6.35 ± 0.75 ns
ns 58 ns 58 60 ns
ns 17 0.020 12 30 ns
ns 79 ns 79 80 ns
<0.0001 65 ± 21 0.009 62 ± 13 68 ± 29 ns
<0.0001 45 ± 14 ns 94 ± 6 105 ± 45 ns
<0.0001 42 ± 14 ns 42 ± 9 49 ± 18 ns
ns 277 ± 589 ns 255 ± 580 401 ± 617 ns
ant. CAD: coronary artery disease; LDL: low density lipoprotein; HDL: High
bin Standardization Program, EATV: epicardial adipose tissue volume, BSA:
Figure 2 Comparison of BMI (A), EATV (B), EATV/height (C), and EATV/BSA (D) in non-CAD (○) and CAD (●) subjects. BMI, body mass
index; EATV, epicardial adipose tissue volume; BSA, body surface area. Coronary artery disease (CAD) was defined if one has plaque lesion(s)
resulting in >50% luminal narrowing.
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tween EATV/BSA and Agatston score in the non-CAD
and CAD groups (Figure 4, lower panel).
Correlation between EATV/BSA and variables
When non-CAD and CAD groups were combined,
EATV, EATV/height, and EATV/BSA were not correlated
with BMI (data not shown). Even after segregation intoFigure 3 EATV/BSA in subjects with degrees of coronary
luminal stenosis. Subjects were segregated into the following
categories based on the degree of coronary luminal stenosis
determined using MDCT: grade 0 = no plaque in the major coronary
arteries; grade 1 = ≤25% luminal narrowing; grade 2 = ≤50%
luminal narrowing; grade 3 = >50% luminal narrowing. One-way
ANOVA was performed followed by Tukey-Kramer HSD test.
*p < 0.05 vs. grade 0.non-CAD and CAD groups, EATV/height and EATV/
BSA were not correlated with BMI (Figure 5). When
non-CAD and CAD groups were combined, EATV/
BSA correlated with age in men (r = 0.320; p = 0.032),
and the correlation was lost when men were segregated
into non-CAD and CAD groups (Figure 6). There was
no correlation between EATV/BSA and age in women
(Figure 6). EATV/BSA correlated with the presence of
diabetes mellitus in women (r = 0.431; p = 0.009) but
not in men (r = 0.029; p = 0.657). EATV/BSA was not
correlated with the presence of hypertension and
hyperlipidemia in either men or women.Predictors for coronary atherosclerotic lesions
By univariate logistic regression analysis, presence of co-
ronary atherosclerotic lesions, defined by >50% luminal
narrowing, correlated with EATV, EATV/BSA, EATV/
height, and age in men (Table 2). On the other hand, the
presence of coronary atherosclerotic lesions correlated
with EATV and EATV/BSA in women (Table 2). Body
weight, BMI, systolic and diastolic blood pressure,
HbA1c, triglycerides, LDL- and HDL-cholesterol, and the
presence of hypertension and diabetes mellitus were not
associated with the presence of coronary atherosclerotic
lesions. Multivariate logistic regression analysis indicated
that EATV/BSA was detected as an independent risk fac-
tor for >50% luminal narrowing only in men (Table 3).
BMI, age, presence of hypertension, diabetes mellitus,
and hyperlipidemia were not associated with the pres-
ence of coronary atherosclerotic lesions.
Figure 4 Comparison of Agatston score in Non-CAD (○) and CAD (●) subjects and linear correlation between EATV/BSA and Agatston
score in men and women. EATV, epicardial adipose tissue volume; BSA, body surface area. Coronary artery disease (CAD) was defined if one has
plaque lesion(s) resulting in >50% luminal narrowing. Linear correlation between EATV/BSA and Agatston score in men and women.
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In the present study, we employed a method for asses-
sing total EATV by using 256-slice MDCT and found
that EATV/BSA was comparable between men and
women. We discovered that EATV/BSA was correlated
with the presence of coronary atherosclerosis only in
men. To our knowledge, this is the first study to report
gender disparity in EATV and that EATV is a determin-
ant for coronary atherosclerosis only in men.
Volumetric quantification of EAT
EAT is distributed asymmetrically around the heart and
located mainly at the atrioventricular and interventricu-
lar grooves, around major coronary arteries and the free
wall of the right ventricle, and at the apex of the left
ventricle. In this study, we determined the volume of
EAT by using a volumetric measurement [18-22] and
sought a precise estimate of the EAT volume with an
increased slice range of 300–320 (0.625-mm/slice thick-
ness). The superior border for EATV measurements was
the lower surface of the left pulmonary artery origin,
while the inferior border was the left ventricular apex.
All epicardial fat surrounding the proximal, middle, anddistal segment of major coronary arteries was included
in the volumetric measurement. It is assumed that our
measure employed reliable volumetric quantification of
total EAT volume.Gender and age difference in EATV
Mean EAT volume was higher in men than in women,
while mean EATV/BSA did not differ significantly be-
tween them. Although EATV is used as the sole mar-
ker of epicardial adiposity in most previous studies
[18,19] barring a few [7], EATV corrected by BSA can
serve as a more accurate and reliable marker for as-
suming atherosclerotic risk among various types of
constitution samples. In our study, EATV/BSA was not
correlated with BMI in men and women (Figure 5), but
correlated with age in men (r = 0.320; p = 0.030) (Fig-
ure 6) and with the presence of diabetes mellitus in
women (r = 0.431; p = 0.009). EATV/BSA was not cor-
related with the presence of hypertension nor hyperlip-
idemia in men and women. The above data suggests
that EATV is determined by different factors in men
and women.
Figure 5 Linear correlation between BMI and EATV/height (upper panel) and EATV/BSA (lower panel) in men and women. Lines were
plotted in non-CAD (○) and CAD subjects (●). EATV, epicardial adipose tissue volume; BSA, body surface area. Coronary artery disease (CAD) was
defined if one has plaque lesion(s) resulting in >50% luminal narrowing.
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Several studies have already shown that total EAT vol-
ume measured by CT is associated with the presence of
coronary atherosclerosis [20-22]. Although theFigure 6 Linear correlation between age and EATV/BSA in men and w
respectively. EATV, epicardial adipose tissue volume; BSA, body surface area
resulting in >50% luminal narrowing.comparison of EAT volume in men and women has
been performed previously [24], no studies have
reported the gender-differentiated impact of EAT volume
on coronary atherosclerosis. We found that EATV,omen. Lines were plotted in Non-CAD (○) and CAD subjects (●),
. Coronary artery disease (CAD) was defined if one has plaque lesion(s)
Table 2 Univariate analysis to estimate coronary atherosclerotic lesions in men and women
Men Women
estimate SE P estimate SE P
EATV (cm3) 0.012 0.002 <.0001 0.009 0.004 0.023
EATV/height (cm3/m2) 0.007 0.001 <.0001 0.003 0.002 0.269
EATV/BSA (cm3/m2) 0.021 0.003 <.0001 0.015 0.006 0.015
Body weight (kg) -0.002 0.007 0.737 -0.006 0.010 0.538
BMI (kg/m2) -0.008 0.022 0.730 -0.035 0.024 0.151
Age (years) 0.017 0.005 0.003 -0.009 0.007 0.189
Systolic blood pressure (mmHg) -0.005 0.005 0.339 0.002 0.004 0.534
Diastolic blood pressure (mmHg) 0.006 0.010 0.524 -0.011 0.010 0.319
Hypertension (yes/no) 0.224 0.164 0.181 0.057 0.145 0.698
HbA1c (NGSP %) -0.001 0.069 0.988 -0.006 0.118 0.963
Diabetes mellitus (yes/no) 0.148 0.154 0.340 0.252 0.191 0.197
LDL-cholesterol (mmol/L) 0.004 0.006 0.545 -0.005 0.008 0.570
HDL-cholesterol (mmol/L) -0.014 0.008 0.088 0.003 0.006 0.611
Triglycerides (mmol/L) 0.000 0.001 0.642 0.000 0.001 0.833
Hyperlipidemia (yes/no) 0.200 0.228 0.386 -0.488 0.187 0.018
SE: standard error, CAD: coronary artery disease; LDL: low density lipoprotein; HDL: High density lipoprotein; HbA1c : Glycosylated hemoglobin, NGSP: National
Glycohemoglobin Standardization Program, EATV: epicardial adipose tissue volume, BSA: body surface area.
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CAD than in non-CAD group in men (Table 1,
Figure 2). Higher EATV, EATV/height, and EATV/BSA
were observed both in younger (<65 years) and older
(≥65 years) CAD groups in men (Additional file 1 and
Additional file 2); however, in women, these values did
not differ significantly between non-CAD and CAD
groups. Multivariate regression analysis indicated that
EATV/BSA was strongly correlated with the presence
of atherosclerotic lesions in men. These findings sug-
gest that EAT deposition may be more strongly
involved than total body fat compartments in coronary
atherogenesis, and that epicardial fat deposition plays a






Intercept -1.257 0.603 -2.09
EATV/BSA (cm3/m2) 0.021 0.004 5.52
BMI (kg/m2) 0.004 0.018 0.25
Age (years) 0.010 0.006 1.83
Hypertension (yes/no) -0.044 0.154 -0.29
Diabetes mellitus (yes/no) 0.040 0.117 0.34
Hyperlipidemia (yes/no) 0.012 0.167 0.07
SE: standard error, EATV: epicardial adipose tissue volume; BMI:Body mass index; BSAPotential mechanisms
Our study showed that EAT volume was the most strong
predictor for detecting coronary atherosclerosis. In other
words, EAT could be more closely linked to the develop-
ment and pathogenesis of CAD than other traditional
risk factors such as hypertension, dyslipidemia, obesity,
and diabetes mellitus. Currently, the mechanism by
which EAT volume is associated with coronary athero-
sclerosis only in men is unclear. Three possible mechan-
isms are discussed.
Gender differences in EAT adipocytokine
Numerous studies suggest that the role of coronary risk





P value estimate SE t P value
0.046 0.995 1.560 0.64 0.536
<.0001 0.015 0.008 1.84 0.090
0.805 -0.026 0.032 -0.8 0.440
0.078 -0.009 0.012 -0.74 0.476
0.777 -0.088 0.195 -0.45 0.661
0.736 0.147 0.261 0.56 0.584
0.945 -0.305 0.199 -1.53 0.151
: body surface area.
Dagvasumberel et al. Cardiovascular Diabetology 2012, 11:106 Page 9 of 11
http://www.cardiab.com/content/11/1/106differ in men and women [25-27]. EAT volume is
reported to be associated with visceral adipose tissue
(VAT) volume but not with subcutaneous adipose tis-
sue volume [2,3]. Greater VAT volume is more preva-
lent in men and is strongly associated with metabolic
syndromes [13,14,27,28], suggesting that the gender
differences in this syndrome may contribute to gender
differences in CAD [19]. Park et al. [29] reported that
echocardiographically determined EAT thickness, a
surrogate marker of total EAT volume [30,31], was
significantly increased in patients with metabolic syn-
drome and CAD, but the power of EAT thickness to
predict metabolic syndrome and CAD was stronger in
patients with less BMI (<27 kg/m2). Associations be-
tween whole body fat distribution and EAT volume, in
men and women, need to be clarified in future stud-
ies. EAT volume can be a mere marker of metabolic
syndrome or a local stimulator of atherosclerotic
lesions [1-4,12,32]. Although EATV accounts for ~1%
of the total body fat mass, EAT volume accounts for
15–20% of the total cardiac volume and covers ~80%
of the total cardiac surface [2-4]. Products secreted by
EAT can be delivered to atherosclerotic plaques via
the vasa vasorum [12,32]. It has been reported that
the expression of pro- and anti-inflammatory cytokines
was attenuated in EAT near coronary atherosclerotic
lesions [10,11,33,34]. Zhou et al. reported that
decreased adiponectin mRNA expression was asso-
ciated with enhanced expression of cytokines IL-6,
TNF-α, or TLR4 in EAT [33]. Gao et al. reported that
mRNA and protein expression of chemerin, a novel
adipocytokine regulating immune responses and glu-
cose and lipid metabolism, are higher in EAT of
Chinese patients with CAD [34]. They also showed
that the severity of coronary atherosclerosis is posi-
tively correlated with the chemerin mRNA level in
EAT rather than its circulating level [34]. We previ-
ously reported that the expression of pro-
inflammatory cytokines was positively correlated, and
the expression of anti-inflammatory cytokines was
negatively correlated, with the ratio of M1/M2 macro-
phages in epicardial adipose tissue of CAD patients
[10,11]. Thus, locally produced adipocytokine could
enhance the progression of coronary atherosclerosis
in men.
Gender differences in coronary plaque burden and
composition
Greater CAD event rates in men than in women could
be a result of the differences in coronary artery plaque
burden and composition [35,36]. The coronary plaque
burden is lower in women, and plaque morphology dif-
fers by age and gender [35]. Plaque rupture with a large
necrotic core and disrupted fibrous cap infiltrated bymacrophage and lymphocytes is common in men and
older women, while plaque erosion with no fibrous cap
but with intima consist of smooth muscle and proteogly-
can is common in younger women. Women have rela-
tively less calcified plaques and mixed plaques than men
[36]. Taken together, coronary plaque lesions can be
more strongly activated in men through inflammatory
process which is enhanced in EAT with or without the
underlying metabolic syndrome [10,11]. Because no cor-
relation was found between EATV/BSA and Agatston
score in non-CAD and CAD groups (Figure 4, lower
panel), gender difference in coronary calcified lesion
may not be related to the impact of EATV/BSA on cor-
onary atherosclerosis in our subjects.Gender differences in coronary microvascular function
Angina-like chest pain with angiographically normal cor-
onary arteries affects women more frequently than men
[37]. These individuals often show microvascular dys-
function as detected by reduced coronary blood flow re-
serve (CFR) [38]. In women with microvascular
dysfunction, multivariate regression analysis revealed
epicardial fat thickness as the only independent pre-
dictor of microvascular dysfunction (p < 0.0001), al-
though traditional atherosclerotic risk factors such as
age, hypertension, HOMA-IR, and menopause did not
predict women with abnormal microvascular function
[39]. The impact of EATV on coronary microvascular
dysfunction in men and women should also be studied
in future studies.Limitations
The major limitation of this study is that the results are
not conclusive; The number of patients was very small
to derive definite conclusions, especially when the study
population is divided in subgroups. The number of fe-
male subjects in particular was very small. There is no
power analysis. Furthermore, some of the results of the
study were not as expected, i.e., the absence of associ-
ation of traditional cardiovascular risk factors with cor-
onary artery disease. It appears that more subjects
should be included in order to achieve adequate statis-
tical power.Conclusions
By assessing EAT volume using 256-slice MDCT, we
found that EATV/BSA was comparable in men and
women, but EATV/BSA was an independent risk factor
of significant coronary atherosclerosis in men. Gender
disparity in EAT volume for detection of coronary ath-
erosclerosis prompts us to evaluate new diagnostic strat-
egy and the underlying mechanisms.
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